COMPANY PROFILE

Nutshell Therapeutics

Explore full profile

Inventing small molecule in the realm of drug discovery fostered by protein dynamics

Huangpu, ChinaFounded 2013Biotech & Life Sciences

Valuation $100–250M Last recorded · 2022

Total funding $50–100M Disclosed equity funding

At a glance

Status: Operational
Founded: 2013
Headquarters: Huangpu, China
Open positions: None listed
Dealroom signal: 20.7/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website

Founder mafia, market maps, research and news connected to this company by Dealroom

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES AOther financing	Mar 2022	$40M	$160M	Matrix Partners China · Genesis-Capital · Hengxu Capital · Tencent	↗
SERIES AOther financing	Jun 2021	$20M	$80M	Matrix Partners China · Baidu Ventures · Kunlun Fund · NLVC	↗

Nutshell Therapeutics website traffic

Latest recorded traffic for Nutshell Therapeutics is 460 monthly website visits, up 1433.3% over the last three months.

Latest monthly visits460 3-month web change+1433.3%

Monthly website visitsOct 2022–Jul 2026

Summary metrics are public; monthly history is available with a demoCompare with peers →

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CTCyclone TherapeuticsA preclinical-stage drug discovery company that focuses on improving protein quality control by modulating translation	San Diego, United States	Operational	1	$800K	$3.2M
DBDiffuse BioWe're building push-button software for drug design, driven by breakthroughs in generative AI	San Francisco, United States	Operational
DPDISCO PharmaceuticalsBiotechnological research as well as the development, production and distribution of biotechnological products and solutions of all kinds	Cologne, Germany	Operational
WMWild MicrobesBiotech & Life Sciences	Cambridge, United States	Operational
MOMoleculeMindA leading AI protein design platform company	Haidian, China	Operational
MAMatchpointDesigning a new era of precision covalent medicines informed by breakthroughs in ultradeep chemoproteomics and machine learning	Boston, United States	Operational
CECellshootSearching for drug discovery target molecules and create groundbreaking new drug candidates	Tokyo, Japan	Operational
INInnoRNAProprietary LNP platform for effective mRNA delivery, enabling advanced nucleic acid therapeutics	Shenzhen, China	Operational